I'll be the first to admit that I have very limited knowledge of the pharmaceutical industry, but from what I've gleaned, it's such a tangled, multi-tiered morass of different actors, contracts, and regulations, that it may be a few years before we see any movement on the market's pricing, if at all.

I have a lot of hope for his ambitions to enact a favored nation's policy wrt Medicare's drug pricing, but since his administration's seemingly been lackluster on executing his order limiting insulin markups by federally funded clinics, I doubt his policies are anything other than paper tigers.